Biotech

All Articles

BMS axes bispecific months after submitting to run phase 3 test

.Bristol Myers Squibb has actually had a whiplash change of heart on its BCMA bispecific T-cell enga...

Charles Baum takes control of Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapeutics' $ 5.8 billion purchase to Bristol My...

Asarina to close after efforts to companion Tourette's drug stop working

.After connecting to much more than 200 companies to partner a Tourette syndrome therapy that showed...

Novartis pens $150M upfront bispecifics deal with Dren Bio

.Novartis has actually possessed some rotten luck along with bispecific antibodies previously, howev...

AstraZeneca vegetations an EGFR plant with Pinetree package worth $45M

.Pinetree Rehabs will certainly assist AstraZeneca plant some trees in its own pipeline with a brand...

GRO gathers $60M series B to take gout therapy in to center

.GRO Biosciences has actually finished the full week with an additional $60.3 thousand in the bankin...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops chief executive officer

.Accept to this week's Chutes &amp Ladders, our summary of substantial management hirings, shootings...